3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Ganglioneuroblastoma
3
Breast Neoplasms
3
Neuroblastoma
2
Gliosarcoma
2
Glioblastoma
2
Wilms Tumor
1
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Thyroid Diseases
1
Thyroid Cancer, Papillary
1
Thoracic Diseases
1
Testicular Neoplasms
1
Teratoma
1
Stomach Neoplasms
1
Stage I Prostate Adenocarcinoma AJCC v7
1
Squamous Cell Carcinoma of Head and Neck
1
Skin Neoplasms
1
Seroma
1
Salivary Gland Neoplasms
1
Rhabdomyosarcoma
1
Recurrence
1
Prostatic Neoplasms
1
Polycystic Ovary Syndrome
1
Parathyroid Neoplasms
1
Parathyroid Diseases
1
Pancreatic Neoplasms
1
Ovarian Germ Cell Cancer
1
Neoplasm Metastasis
1
Lymphatic Metastasis
1
Lung Neoplasms
1
Interventions
Surgical Procedures, Operative
2
Radiotherapy
2
Lymph Node Excision
2
lncRNA LNMAT1, human
1
gewf solution
1
gadofosveset trisodium
1
fluoroazomycin arabinoside
1
Thyroidectomy
1
Technetium
1
Surgery, Computer-Assisted
1
Spectrum Analysis
1
Radiotherapy, Intensity-Modulated
1
Radiosurgery
1
Radiation Dose Hypofractionation
1
Methylene Blue
1
Metformin
1
Leuprolide
1
Indocyanine Green
1
Goserelin
1
Esophagectomy
1
Electroporation
1
Docetaxel
1
Cytoreduction Surgical Procedures
1
Congresses as Topic
1
Axitinib
1
Artificial Intelligence
1
Androgen Antagonists
1
Acceleration
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Lymphatic Metastasis
×
Congresses as Topic
×
Clear all
NCT05867095
2023-05-19
N16LND
The Netherlands Cancer Institute
Phase NA
Completed
69 enrolled